Piper Sandler reiterated coverage on Neoleukin Therapeutics with a new price target

3/2/22 8:41:36 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Piper Sandler reiterated coverage of Neoleukin Therapeutics with a rating of Overweight and set a new price target of $25.00 from $30.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NLTX

Date	Price Target	Rating	Analyst
3/2/2022	$30.00 → $25.00	Overweight	Piper Sandler
8/6/2021	$30.00	Overweight	Piper Sandler